DK163429C - Carbostyrilderivat og farmaceutisk acceptable salte deraf, saadanne forbindelser til anvendelse som positive inotropiske midler, anvendelse af forbindelserne til fremstilling af farmaceutiske praeparater, farmaceutiske praeparater indeholdende en saadan forbindelse, samt fremgangsmaade til forbindelsernes fremstilling - Google Patents

Carbostyrilderivat og farmaceutisk acceptable salte deraf, saadanne forbindelser til anvendelse som positive inotropiske midler, anvendelse af forbindelserne til fremstilling af farmaceutiske praeparater, farmaceutiske praeparater indeholdende en saadan forbindelse, samt fremgangsmaade til forbindelsernes fremstilling

Info

Publication number
DK163429C
DK163429C DK680887A DK680887A DK163429C DK 163429 C DK163429 C DK 163429C DK 680887 A DK680887 A DK 680887A DK 680887 A DK680887 A DK 680887A DK 163429 C DK163429 C DK 163429C
Authority
DK
Denmark
Prior art keywords
carbonly
carrially
carbostyle
car
division
Prior art date
Application number
DK680887A
Other languages
English (en)
Other versions
DK680887A (da
DK163429B (da
DK680887D0 (da
Inventor
Arthur Page Phillips
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK680887D0 publication Critical patent/DK680887D0/da
Publication of DK680887A publication Critical patent/DK680887A/da
Publication of DK163429B publication Critical patent/DK163429B/da
Application granted granted Critical
Publication of DK163429C publication Critical patent/DK163429C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Secondary Cells (AREA)
  • Carbon And Carbon Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Quinoline Compounds (AREA)
DK680887A 1986-12-23 1987-12-22 Carbostyrilderivat og farmaceutisk acceptable salte deraf, saadanne forbindelser til anvendelse som positive inotropiske midler, anvendelse af forbindelserne til fremstilling af farmaceutiske praeparater, farmaceutiske praeparater indeholdende en saadan forbindelse, samt fremgangsmaade til forbindelsernes fremstilling DK163429C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8630702 1986-12-23
GB868630702A GB8630702D0 (en) 1986-12-23 1986-12-23 Quinoline compound

Publications (4)

Publication Number Publication Date
DK680887D0 DK680887D0 (da) 1987-12-22
DK680887A DK680887A (da) 1988-06-24
DK163429B DK163429B (da) 1992-03-02
DK163429C true DK163429C (da) 1992-07-20

Family

ID=10609475

Family Applications (1)

Application Number Title Priority Date Filing Date
DK680887A DK163429C (da) 1986-12-23 1987-12-22 Carbostyrilderivat og farmaceutisk acceptable salte deraf, saadanne forbindelser til anvendelse som positive inotropiske midler, anvendelse af forbindelserne til fremstilling af farmaceutiske praeparater, farmaceutiske praeparater indeholdende en saadan forbindelse, samt fremgangsmaade til forbindelsernes fremstilling

Country Status (22)

Country Link
US (1) US4937248A (da)
EP (1) EP0272910B1 (da)
JP (1) JPS63166866A (da)
KR (1) KR880007514A (da)
AT (1) ATE65993T1 (da)
AU (1) AU594220B2 (da)
CA (1) CA1318671C (da)
DE (1) DE3772015D1 (da)
DK (1) DK163429C (da)
ES (1) ES2029842T3 (da)
FI (1) FI90768C (da)
GB (1) GB8630702D0 (da)
GR (1) GR3002445T3 (da)
HU (1) HU196991B (da)
IE (1) IE60619B1 (da)
IL (1) IL84917A (da)
MX (1) MX9203788A (da)
MY (1) MY102277A (da)
NZ (1) NZ223036A (da)
PH (1) PH23448A (da)
PT (1) PT86448B (da)
ZA (1) ZA879615B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166160A (en) * 1986-12-23 1992-11-24 Burroughs Wellcome Co. Quinoline compound
GB8820174D0 (en) * 1988-08-25 1988-09-28 Wellcome Found Quinoline compound
BR9813216A (pt) * 1997-09-24 2000-08-29 Orion Corp Biésteres de 1-oxa, aza e tianaftalen-2-onas como inibidores de fosfolamban
MXPA02002032A (es) 1999-08-27 2003-05-19 Ligand Pharm Inc Compuestos moduladores del receptor de androgeno y metodos.
US6566372B1 (en) 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
EP1212322A2 (en) 1999-08-27 2002-06-12 Ligand Pharmaceuticals Incorporated 8-substituted-6-trifluoromethyl-9-pyrido[3,2-g]quinoline compounds as androgen receptor modulators
EP1216221A2 (en) 1999-09-14 2002-06-26 Ligand Pharmaceuticals Incorporated Rxr modulators with improved pharmacologic profile
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
AU2004266160A1 (en) 2003-08-22 2005-03-03 Ligand Pharmaceuticals Incorporated 6-cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EA201391254A1 (ru) 2011-03-01 2014-02-28 Синерджи Фармасьютикалз Инк. Способ получения агонистов гуанилатциклазы c
JP6499591B2 (ja) 2013-02-25 2019-04-10 シナジー ファーマシューティカルズ インコーポレイテッド 結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
JP2016514671A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼのアゴニストおよびその使用
CN105764916B (zh) 2013-06-05 2021-05-18 博士医疗爱尔兰有限公司 鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法
EP3492106B1 (en) 2013-08-09 2021-02-17 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
EP3972599B1 (en) 2019-05-21 2025-10-22 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2616855A (en) * 1948-01-15 1952-11-04 Procter & Gamble Detergent composition
US4329347A (en) * 1978-02-17 1982-05-11 Boehringer Ingelheim Gmbh Cardiotonic and antithrombotic sulfur-containing derivatives of carbostyril
JPS5777676A (en) * 1980-10-31 1982-05-15 Otsuka Pharmaceut Co Ltd Carbostyril derivative
PT79699B (en) * 1983-12-22 1986-12-10 Pfizer Process for preparing quinolone inotropic agents
GR851296B (da) * 1984-05-29 1985-11-25 Pfizer
US4760064A (en) * 1984-12-18 1988-07-26 Otsuka Pharmaceutical Co., Ltd. Carbostyril compounds, compositions containing same and processes for preparing same
US4845100A (en) * 1985-04-12 1989-07-04 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives and salts thereof, processes for preparing the same and cardiotonic composition containing the same
FR2580646A1 (fr) * 1985-04-19 1986-10-24 Synthelabo Derives de 2(1h)-quinolinone, leur preparation et leur application en therapeutique
GB8529362D0 (en) * 1985-11-28 1986-01-02 Pfizer Ltd Quinolone cardiac stimulants
DK111387A (da) * 1986-03-05 1987-09-06 Otsuka Pharma Co Ltd Carbostyrilderivater og salte deraf, laegemiddel indeholdende saadanne derivater samt fremgangsmaade til fremstilling af derivaterne
EP0255134B1 (en) * 1986-07-31 1993-03-03 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives and salts thereof, process for preparing them, and cardiotonic composition containing same

Also Published As

Publication number Publication date
FI90768C (fi) 1994-03-25
DK680887A (da) 1988-06-24
HU196991B (en) 1989-02-28
FI875666A0 (fi) 1987-12-22
EP0272910B1 (en) 1991-08-07
PH23448A (en) 1989-08-07
CA1318671C (en) 1993-06-01
PT86448A (en) 1988-01-01
ES2029842T3 (es) 1992-10-01
PT86448B (pt) 1990-11-20
JPS63166866A (ja) 1988-07-11
FI90768B (fi) 1993-12-15
EP0272910A1 (en) 1988-06-29
DK163429B (da) 1992-03-02
KR880007514A (ko) 1988-08-27
IL84917A0 (en) 1988-06-30
IE873490L (en) 1988-06-23
FI875666L (fi) 1988-06-24
DE3772015D1 (de) 1991-09-12
AU8293387A (en) 1988-06-23
US4937248A (en) 1990-06-26
HUT45984A (en) 1988-09-28
DK680887D0 (da) 1987-12-22
NZ223036A (en) 1990-11-27
GB8630702D0 (en) 1987-02-04
ZA879615B (en) 1989-08-30
MX9203788A (es) 1992-07-01
IE60619B1 (en) 1994-07-27
GR3002445T3 (en) 1992-12-30
IL84917A (en) 1991-08-16
ATE65993T1 (de) 1991-08-15
AU594220B2 (en) 1990-03-01
MY102277A (en) 1992-05-15

Similar Documents

Publication Publication Date Title
DK163429C (da) Carbostyrilderivat og farmaceutisk acceptable salte deraf, saadanne forbindelser til anvendelse som positive inotropiske midler, anvendelse af forbindelserne til fremstilling af farmaceutiske praeparater, farmaceutiske praeparater indeholdende en saadan forbindelse, samt fremgangsmaade til forbindelsernes fremstilling
DK502781A (da) Fremgangsmaade til fremstilling af 3-aryloxy-3-phenylpropylaminer
DE69132435D1 (de) Inhibitoren retroviraler Proteasen
FI903331A0 (fi) Substituerade kinazolinoner, vilka aer anvaendbara som angiotensin-ii-antagonister.
DK262585A (da) Polypeptider og salte deraf samt fremgangsmaade til fremstilling af saadanne forbindelser
ES557582A0 (es) Un procedimiento para preparar derivados de (benzoil-4-piperidinil-1)-2-fenil-1-alcanoles
DK506587D0 (da) Imidderivater
DK397387D0 (da) Carbostyrilderivater og salte deraf samt fremgangsmaade til fremstilling af saadanne forbindelser
FI864017A0 (fi) 3-vinyl och 3-etynyl- -karbolinderivat, deras framstaellning och deras anvaendning som laekemedel.
ES2086917T3 (es) Procedimiento para preparar compuestos de diestirilbifenilo.
DK0589322T3 (da) 5-Oxo-dibenzo a,d cyclohepta-1,4-diener samt deres anvendelse som retrovirale midler.
ES524386A0 (es) Procedimiento para la obtencion de muramilpeptidos
DK0480155T3 (da) 4-Substituerede dihydropyrido(4,3-d)pyrimidiner som analgetica og topiske antiinflammatoriske midler til behandling af hudlidelser
DK262685D0 (da) Polypeptider og salte deraf samt fremgangsmaade til fremstilling af saadanne forbindelser
DK248788D0 (da) Bicycliske sulfonamidderivater samt fremgangsmaade til fremstilling deraf
ATE63910T1 (de) Diphenyletherderivate.
DE69315712D1 (de) 2,4-Diamino-1,3,5-Triazinyl-6-Phosphonsäurederivate
DK232883D0 (da) Fremgangsmade til fremstilling af optisk aktive imidazolylpropanolforbindelser
ES544709A0 (es) Procedimiento para la obtencion de iminosulfonamidas
ATE47841T1 (de) 5-sulfonamido-1-aryl-pyrazole.

Legal Events

Date Code Title Description
PBP Patent lapsed